PBH

Prestige Consmr Healthcare Inc

62.09

0.28+0.45%

After Hours: 62.84 +0.75 +1.21%17:21 10/17 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE61.54/61.81

TODAY RANGE61.44-62.52

VOL325.02K

MARKET CAP3.06B

52 WEEK RANGE60.15-90.04

AVG VOL (3M)528.58K

% TURNOVER0.66%

TURNOVER--

P/E (TTM)14.57

% RANGE1.75%

EPS(TTM)4.262

P/E(FORWARD)13.77

P/B1.647

BVPS37.70

DIVIDEND--

P/S2.702

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP3.02B

SHARES OUTSTANDING49.21M

NEXT EARNINGS11/05-11/10

FREE FLOAT48.58M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

NASDAQ·3d ago
December 19th Options Now Available For Prestige Consumer Healthcare (PBH)
TipRanks·09/24 11:30
Prestige Consumer upgraded to Buy from Neutral at Sidoti
NASDAQ·09/19 12:40
Implied Volatility Surging for Prestige Consumer Stock Options
Seeking Alpha·09/18 03:07
Tracking John Rogers' Ariel Investments Portfolio - Q2 2025 Update
NASDAQ·09/15 16:56
Prestige Consumer Healthcare Becomes Oversold (PBH)
Seeking Alpha·09/04 19:56
Prestige Consumer Healthcare: Elevated Debt And Limited Growth Prospects
TipRanks·08/14 13:28
Buy Rating for Prestige Consumer Healthcare: Strategic Initiatives and Resilience Drive Growth Potential
TipRanks·08/12 00:21
Prestige Consumer Healthcare’s Cautious Earnings Call Outlook
Dow Jones·08/08 21:41
Prestige Consumer Hlthcr Price Target Cut to $100.00/Share From $105.00 by Canaccord Genuity
Dow Jones·08/08 21:41
Prestige Consumer Hlthcr Is Maintained at Buy by Canaccord Genuity
TipRanks·08/08 11:00
Prestige Consumer price target lowered to $100 from $105 at Canaccord
Seeking Alpha·08/08 06:39
Prestige Consumer Healthcare outlines $1.1B-$1.115B FY26 revenue target amid Pillar5 acquisition and Clear Eyes supply recovery
TipRanks·08/08 04:26
Prestige Consumer Healthcare’s Q1 Earnings and Strategic Moves
Dow Jones·08/07 18:13
Prestige Consumer Healthcare Stock Slides on Outlook Cut as 1Q Results Miss Estimates
Dow Jones·08/07 16:27
Prestige Consumer Healthcare Down Over 8%, on Pace for Largest Percent Decrease Since February 2023 -- Data Talk

Same Industry

Name/Symbol

Change%

Price

Prestige Consmr Healthcare Inc

PBH

+0.45%

62.09

McKesson

MCK

+1.36%

786.00

Biogen Inc

BIIB

+0.52%

143.00

Amgen Inc

AMGN

+1.01%

298.81

Shire

SHPG

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-0.32%

0.0313

Celgene

CELG

108.24

Lilly Eli & Co

LLY

-2.02%

802.83

Therapeuticsmd Inc

TXMD

+19.62%

1.25

Johnson & Johnson

JNJ

+0.57%

193.22

Abbvie Inc

ABBV

+1.19%

229.57

Zoetis Inc

ZTS

+0.56%

144.06

Gilead Sciences Inc

GILD

+4.21%

122.81

Novo-Nordisk A/S

NVO

-3.07%

54.37

Bristol-Myers Squibb Co

BMY

+0.55%

43.63

Pfizer

PFE

+1.16%

24.51

Alexion Pharms

ALXN

+1.70%

182.50

Sanofi FR

SNY

+1.20%

50.62

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

+0.50%

131.43

Dr Reddys Labs

RDY

+1.62%

14.45

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.